Apogee Therapeutics, Inc. (NASDAQ: APGE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT APOGEE THERAPEUTICS, INC.

Apogee Therapeutics, Inc. (NASDAQ: APGE)
Listen to this Section


$134.18
+0.0300 ( +0.02% ) 264.2K

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Market Data


Open $134.18
Previous Close $134.15
Volume 264.2K
Market Cap $10.15B
Day Range $133.60 - $134.60
52 Week Range $34.34 - $134.60
Shares Outstanding 75.63M
Change % +0.02%
Net Change ▲ 0.0300
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2023
CountryUnited States
UnderwriterJefferies, TD Cowen, Stifel, Guggenheim Securities, Wedbush Securities, more

Insider Ownership Transactions

Total Amount Purchased: 365,853.00

Date Type Amount Purchased Purchaser
2025-10-15 Buy 365853.00 Shah Nimish P

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Aug 11, 2025
4 Insider transactions 1 Aug 08, 2025
8-k 8K-related 45 Jul 07, 2025
4 Insider transactions 1 Jul 03, 2025

Latest News